BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34513724)

  • 1. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Innes AJ; Mullish BH; Ghani R; Szydlo RM; Apperley JF; Olavarria E; Palanicawandar R; Kanfer EJ; Milojkovic D; McDonald JAK; Brannigan ET; Thursz MR; Williams HRT; Davies FJ; Marchesi JR; Pavlů J
    Front Cell Infect Microbiol; 2021; 11():684659. PubMed ID: 34513724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
    Ghani R; Mullish BH; McDonald JAK; Ghazy A; Williams HRT; Brannigan ET; Mookerjee S; Satta G; Gilchrist M; Duncan N; Corbett R; Innes AJ; Pavlů J; Thursz MR; Davies F; Marchesi JR
    Clin Infect Dis; 2021 Apr; 72(8):1444-1447. PubMed ID: 32681643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond
    Yoon YK; Suh JW; Kang EJ; Kim JY
    Ann Med; 2019; 51(7-8):379-389. PubMed ID: 31468999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of colonization by multidrug-resistant organisms after allogeneic hematopoietic cell transplantation.
    Heidenreich D; Kreil S; Jawhar M; Müller N; Nolte F; Becker KP; Miethke T; Hofmann WK; Klein SA
    Ann Hematol; 2018 Dec; 97(12):2501-2508. PubMed ID: 30121845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant organisms in allogeneic hematopoietic cell transplantation.
    Heidenreich D; Kreil S; Nolte F; Hofmann WK; Miethke T; Klein SA
    Eur J Haematol; 2017 May; 98(5):485-492. PubMed ID: 28135011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction.
    Seong H; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Jeong WY; Lee WJ; Sohn Y; Cho Y; Hyun JH; Baek YJ; Kim MH; Kim JH; Ahn JY; Ku NS; Jeong SJ; Yeom JS; Cho MS; Lee JH; Kim BY; Choi JY
    J Infect; 2020 Nov; 81(5):719-725. PubMed ID: 32920061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
    Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
    Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.
    Woodworth MH; Conrad RE; Haldopoulos M; Pouch SM; Babiker A; Mehta AK; Sitchenko KL; Wang CH; Strudwick A; Ingersoll JM; Philippe C; Lohsen S; Kocaman K; Lindner BG; Hatt JK; Jones RM; Miller C; Neish AS; Friedman-Moraco R; Karadkhele G; Liu KH; Jones DP; Mehta CC; Ziegler TR; Weiss DS; Larsen CP; Konstantinidis KT; Kraft CS
    Sci Transl Med; 2023 Nov; 15(720):eabo2750. PubMed ID: 37910603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
    Scheich S; Lindner S; Koenig R; Reinheimer C; Wichelhaus TA; Hogardt M; Besier S; Kempf VAJ; Kessel J; Martin H; Wilke AC; Serve H; Bug G; Steffen B
    Cancer; 2018 Jan; 124(2):286-296. PubMed ID: 28960264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.
    Battipaglia G; Malard F; Rubio MT; Ruggeri A; Mamez AC; Brissot E; Giannotti F; Dulery R; Joly AC; Baylatry MT; Kossmann MJ; Tankovic J; Beaugerie L; Sokol H; Mohty M
    Haematologica; 2019 Aug; 104(8):1682-1688. PubMed ID: 30733264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    J Clin Oncol; 2023 Dec; 41(34):5306-5319. PubMed ID: 37235836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review.
    Saha S; Tariq R; Tosh PK; Pardi DS; Khanna S
    Clin Microbiol Infect; 2019 Aug; 25(8):958-963. PubMed ID: 30986562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study.
    Scheich S; Reinheimer C; Brandt C; Wichelhaus TA; Hogardt M; Kempf VAJ; Brunnberg U; Brandts C; Ballo O; von Metzler I; Kessel J; Serve H; Steffen B
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1455-1462. PubMed ID: 28528711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tube.
    Lee EH; Lee SK; Cheon JH; Koh H; Lee JA; Kim CH; Kim JN; Lee KH; Lee SJ; Kim JH; Ahn JY; Jeong SJ; Ku NS; Yong DE; Yoon SS; Yeom JS; Choi JY
    J Hosp Infect; 2023 Jan; 131():234-243. PubMed ID: 36414164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
    DeFilipp Z; Hohmann E; Jenq RR; Chen YB
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection.
    Ghani R; Mullish BH; Davies FJ; Marchesi JR
    Clin Microbiol Infect; 2022 Apr; 28(4):502-512. PubMed ID: 34826617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
    Bulow C; Langdon A; Hink T; Wallace M; Reske KA; Patel S; Sun X; Seiler S; Jones S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30463925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
    DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract - a systematic review.
    Bilsen MP; Lambregts MMC; van Prehn J; Kuijper EJ
    Curr Opin Gastroenterol; 2022 Jan; 38(1):15-25. PubMed ID: 34636363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.